Shumpei Obata
15PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|May 07, 2025
Visual fields after anti-vascular endothelial growth factor therapy for retinopathy of prematurity.Kazuki Imai, Shumpei Obata, Riko Matsumoto
|Sep 06, 2023
Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity.Shumpei Obata, Riko Matsumoto, Maki Iwasa
|Jun 08, 2023
Effects of internal limiting membrane peeling on anatomical and functional outcomes in macula-off rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy: Japan-Retinal Detachment Registry.Shumpei Obata, Osamu Sawada, Masashi Kakinoki
|May 26, 2023
Response to a letter to the editor related to Graefe's Arch Clin Exp Ophthalmol. 2023 April; 261(4):951-957. "Blood neutrophil-to-lymphocyte ratio as a risk factor in the treatment of retinopathy of prematurity".Shumpei Obata, Takahide Yanagi, Masahito Ohji
|May 04, 2023
Association between treatment for retinopathy of prematurity and blood monocyte counts.Shumpei Obata, Riko Matsumoto, Masashi Kakinoki
|Mar 02, 2023
Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes.Shumpei Obata, Masashi Kakinoki, Osamu Sawada
Pageof 3
